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The effect of signal transduction-related factors was investigated to clarify the expression mechanism for mRNA of the hepatic Ca”-binding protein 
regucalcin in the liver of rats. The change of regucalcin mRNA levels was analyzed by Northern blotting using liver regucalcin cDNA (0.6 kb). 
A single intraperitoneal administration of calcium chloride (I 5 mg Ca’+: 0.374 mmol/lOO g body weight) to rats induced a remarkable increase 
of regucalcin mRNA in liver: the level was about 170% of controls at 30 min after administration. This increase was completely inhibited by 
simultaneous administration of trifluoperazine (5.0 mg/lOO g), an antagonist of calmodulin. On the other hand, a single intraperitoneal administra- 
tion of phorbol ester or dibutyryl CAMP (10~1,000 pug/l00 g) did not cause a significant alteration of hepatic regucalcin mRNA levels. Also, 
administration of zinc, copper and cadmium (0.374 mmol of metal ion/l00 g) did not have an appreciable effect on hepatic regucalcin mRNA levels. 
These findings demonstrate that the expression of hepatic regucalcin mRNA is mediated through Ca”/calmodulin. 
Regucalcin: Calcium; Calmodulin; Gene expression; Northern blot analysis; Rat liver 
1. INTRODUCTION 
Calcium ion (Ca”) plays an important role in the 
regulation of many cell functions, and its part in liver 
metabolism has been demonstrated. Liver metabolism 
is regulated by an increase of Ca2+ in the cytosol of liver 
cells due to hormonal stimulation. The Ca’+ effect is 
amplified by calmodulin and protein kinase C [1,2]. 
On the other hand, it has been recognized that a novel 
Ca”-binding protein, which differs from calmodulin, is 
distributed in the hepatic cytosol of rats [3-91. The name 
regucalcin was proposed for this Ca”-binding protein, 
which may regulate the Ca’+ effect on liver cell function. 
Regucalcin has a reversible effect on the activation and 
inhibition of various enzymes by Ca’+ in liver cells. 
Recently, it was reported that regucalcin can inhibit the 
activation of Ca”/calmodulin-dependent cyclic AMP 
phosphodiesterase [7], protein kinase C [5] and Ca’+- 
activated DNA fragmentation [8] due to binding of 
Ca’+. 
More recently, we have reported that the expression 
of regucalcin mRNA is specific in the liver of various 
tissues and that it is increased by the administration of 
calcium chloride to rats [lo]. Therefore, the present in- 
vestigation was undertaken to clarify a possible regula- 
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tory mechanism for the expression of regucalcin mRNA 
by Northern blot analyses with hepatic regucalcin 
cDNA as a probe. It was found that the calcium admin- 
istration-induced increase in rat hepatic mRNA levels 
is completely inhibited by treatment with an antagonist 
of calmodulin, trifluoperazine. 
2. MATERIALS AND METHODS 
Deoxycytidine 5’-[a-“Pltriphosphate ([“P]dCTP); 110 Tbq/mmol 
and nylon membranes (Hybond Nf) for Northern hybridization were 
obtained from Amersham (Buckinghamshire, UK). A human/I-a&n 
gene fragment (0.43 kb) as an internal standard was obtained from 
Wako Pure Chemical Co. (Osaka. Japan). Molecular-size standards 
(0.24- 9.5 kb RNA Ladder) for electrophoresis of RNA was purchased 
from Bethesda Research Laboratories (Gaithersburg, MD). Trifluo- 
perazine dimaleate (TFP), phorbol 12.myristate 13-acetate (PMA), 
and dibutyryl cyclic-adenosine 3’.5’-monophosphate sodium (dibu- 
tyryl CAMP) were obtained from Sigma Chemical Co. (St. Louis, 
MO). Calcium chloride and other reagents were purchased from 
Wako Pure Chemical Co. Any water and solutions used for RNA 
preparation were treated with chemical diethylpyrocarbonate (DEPC, 
Sigma) to inhibit RNase activity. 
2.2. Animu1.c 
Male Wistar rats, weighing 80-100 g, purchased from Japan SLC 
Inc. (Hamamatsu, Japan), were fed commercial laboratory chow 
(solid, Oriental Yeast Co., Ltd., Tokyo) containing 57.5% carbohy- 
drate, 1.1% calcium and 1 .l% phosphorus, and distilled water. ad 
libitum. 
2.3. Administrution procedure 
CaCl?. ZnSO,, CuSO, and CdCI, were dissolved in sterile distilled 
water at a concentration of 0.374 mmol metal ions per ml. Also, TFP 
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(5.0 mg/ml), PMA (10, 100 and l,OOO~g/ml), and dibutyryl CAMP (IO, 
100 and 1,000 &ml) were dissolved in sterile distilled water. These 
solutions (1.0 ml/100 g body weight) were intraperitoneally adminis- 
tered to rats, At 30 min after the administration, the rats were sacri- 
ficed by bleeding. The livers were perfused with ice-cold 0.25 M su- 
crose solution and immediately removed and frozen at -80°C. Con- 
trol animals received vehicle solution. 
2.4. Isolation of RNA 
Hepatic total RNAs were prepared as described [I I]. Liver was 
quickly removed, rinsed with ice-cold 0.25 M sucrose solution, and 
homogenized in buffer solution containing 4 M guanidinium thiocya- 
nate, 25 mM sodium citrate (pH 7) 0.5% sarcosyl, 0.1 M 2-mercap- 
toethanol and 2 M sodium acetate. Total RNAs were extracted by 
vigorous shaking in a mixture of phenol, chloroform and isoamyl 
alcohol, and the phases were separated by centrifugation at 10,000 x 
g for 20 min at 4°C. RNA located in the aqueous phase was precipi- 
tated with isopropanol at -20°C. RNA precipitates were pelleted by 
centrifugation, and the pellets were redissolved in 50 ,uI of DEPC- 
treated 0.5% sodium dodecyl sulfate (SDS). 
2.5. Northern blotting 
Ten micrograms of total RNAs extracted from each tissue were 
electrophoresed in 1.2% agarose denaturing gels containing 2.2 M 
formaldehyde in MOPS buffer (pH 7, containing 20 mM 3-N-mor- 
phohno-propanesulfonic acid, 5 mM sodium acetate, and 1 mM 
EDTA) with 3 V/cm for 3 h [12]. The electrophoresed gels were trans- 
ferred to nylon membranes by blotting [12]. Part of regucalcin cDNA 
(the 0.6 kb, KpnI-PstI insert) was labeled with [“P]dCTP by random 
primers with the DNA polymerase Klenow fragment [13]. This radio- 
active probe was used for hybridization detection of RNAs on blots. 
The membranes were prehybridized, and hybridized in buffer solution 
containing 50% formamide, 5 x SSPE (I x SSPE; 1.15 M NaCl, 10 mM 
NaH?PO,, 1 mM EDTA), 5 x Denhardt’s reagent (1 x Denhardt’s 
reagent; 0.02% w/v each of bovine serum albumin, Ficoll, polyvi- 
nylpyrrolidine) and 0.5% SDS with “P-labeled regucalcin cDNA in a 
sealed plastic bag at 42°C for 16 h. After hybridization themembranes 
were washed as follows: 2 x SSPE and 0.1% SDS at 42°C (twice, each 
for 15 min), followed by 0.1 x SSPE and 0.1% SDS at room tempera- 
ture (twice. each for 15 min), and then the membranes were exposed 
to X-ray film for 12 h. 
Quantity and integrity of mRNA were monitored by rehybridizing 
with a radioactive cDNA probe from human /3-actin gene fragment 
under identical conditions. No noticeable change in the level of RNA 
hybridized with the p-actin probe was observed throughout present 
experiments (data not shown). The size of the hybridizing RNA was 
determined by running the standard RNA molecules of known sizes 
in parallel. The density of the autoradiographic data was quantified 
by densitometer scanning (Dual-wavelength Flying-spot Scanner, CS- 
9000, Shimadzu Co., Japan). 
. 
Fig. 1. Effect of the administration of various metals on regucalcin mRNA levels in the liver of rats. Animals received a single intraperitoneal 
administration of the indicated metal ion (0.374 mmol/lOO g body weight), and 30 min later they were sacrificed by bleeding. Control animals (C) 
received an equivalent volume of distilled water. Total RNA (10 pug) isolated from the liver were subjected to Northern blot analysis. The pattern 
of hybridization obtained with rat liver regucalcin cDNA is shown. The arrowhead indicates hybridizing bands corresponding to mRNA encoding 
regucalcin. The figure shows one of four experiments with separate rats. 
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Fig. 2. Effect of the calmodulin antagonist (TFP) administration on regucalcin mRNA levels in the liver of rats. Animals received a single 
intraperitoneal administration of calcium (Ca, 15 mgllO0 g body weight) or TFP (T, 5.0 mg/tOO g) or both (Ca+T), and 30 min Iater they were 
sacrificed by bleeding. Control animals (C) received an equivalent volume of distilled water. Total RNA (IOpg) isolated from the liver were subjected 
to Northern blot analysis. The pattern of hybridization obtained with rat liver regucalcin cDNA is shown. The arrowhead indicates hybridizing 
bands corresponding to mRNA encoding the regucalcin. The figure shows one of four experiments with separate rats. 
3. RESULTS 
The effect of various metals on regucalcin mRNA in 
the liver of rats is shown in Fig. 1. The various metals 
(calcium, zinc, copper, and cadmium; 0.374 mmol/lOO 
g body weight) were intraperitoneally administered to 
rats, and the animals were sacrificed 30 min after the 
administration. Previous expe~ments showed that the 
hepatic regucalcin mRNA level is markedly increased 
by the administration of calcium (0.374 mmol/lOO g 
body weight) 191. Hepatic regucalcin mRNA was mark- 
edly increased by calcium administration; the level was 
about 170% of control. Meanwhile, the expression of 
regucalcin mRNA was not appreciably altered by the 
administration of zinc, copper and cadmium. Thus, the 
expression of liver regucalcin mRNA was unique for 
calcium out of the various metals used. 
The effect of an antagonist of calmodulin (TFP) on 
regucalcin mRNA in the liver of rats is shown in Fig. 
2. The administration of calcium (15 mg (0.374 mmol)/ 
100 g body weight) caused a remarkable increase in the 
regucalcin mRNA level. When calcium (1.5 mg/lOO g 
body weight) and TFP (5.0 mg/lOO g body weight) were 
administered simultaneously, TFP completely blocked 
the effect of calcium. The administration of TFP alone 
(5.0 m~lO0 g body weight) caused a slight decrease of 
the hepatic regucalcin mRNA level. Thus, the calcium 
administration-increased expression of hepatic regucal- 
tin mRNA was mediated through calmodulin. 
Then, the effect of other signal transduction related 
factors was examined. The effect of PMA, a phorbol 
ester which activates protein kinase C (PKC), on the 
expression of regucalcin mRNA in the liver of rats is 
shown in Fig. 3. The solution of PMA (IO, 100 and 
1,000 &lOO g body weight) was administered intraper- 
itoneally to rats, and the animals were sacrificed 30 min 
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Fig. 3. Effect of increasing doses of PMA on regucalcin mRNA levels in the liver of rats. Animals received a single intraperitoneal administration 
of calcium (Ca, 15 mg/lOO g body weight) or PMA (10, 100 and 1 ,OOO~g/100 g), and 30 min later they were sacrificed by bleeding. Control animals 
(C) received an equivalent volume of distilled water. Total RNAs (10 pug) isolated from the liver were subjected to Northern blot analysis. The 
pattern of hybridization obtained with rat liver regucalcin cDNA is shown. The arrowhead indicates hybridizing bands corresponding to mRNA 
encoding the regucalcin. The figure shows one of four experiments with separate rats. 
after the administration. The expressional change in 
hepatic regucalcin mRNA by the administration of 
PMA was not observed at any doses. 
Moreover, the effect of dibutyryl cAMP on the ex- 
pression of regucalcin mRNA in rat liver was examined, 
and the results are shown in Fig. 4. The expression of 
hepatic regucalcin mRNA was not altered by the ad- 
ministration of dibutyryl CAMP (IO, 100 and 1,000 pg/ 
100 g body weight), as compared with that of control 
rats. 
4. DISCUSSION 
clarified so far. More recent investigations demonstrate 
that regucalcin mRNA is mainly distributed in the liver 
of rats, and that the expression is increased by the ad- 
ministration of calcium; the mRNA level was clearly 
increased at the early time point (within 30 min) of 
calcium administration [IO]. Presumably, regucalcin 
mRNA expression is stimulated by increasing calcium 
in liver cells. Furthermore, the present study was under- 
taken to clarify a possible reguiatory mechanism of the 
expression of regucalcin mRNA in the liver of rats. 
Regucalcin mRNA levels in rat liver was estimated by 
Northern blot analyses with a hepatic regucalcin cDNA 
probe. 
A novel calcium-binding protein regucalcin, isolated First, the effect of various metal ions on the expres- 
from rat liver cytosol, differs from other calcium-bind- sion of regucalcin mRNA in rat liver was examined. A 
ing protein such as calmodulin [3-91. Regucalcin can single intraperitoneal administration of zinc, copper or 
regulate the Ca” effect on liver cell function. The ex- cadmium with a dose of 0.374 mmol/lOO g body weight 
pression of the regucalcin gene, however, is not fully did not cause an appreciable increase of regucalcin 
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Fig. 4. Effect of increasing doses of dibutyryl CAMP on regucalcin mRNA levels in the liver of rats. Animals received a single intraperitoneal 
administration of calcium (Ca. 15 mg/lOO g body weight) or dibutyryl CAMP (IO, 100 and 1,000 ,~ug/lOO g), and 30 min later they were sacrificed 
by bleeding. Control animals (C) received an equivalent volume of distilled water. Total RNAs (I 0 pg) isolated from the liver were subjected to 
Northern blot analysis. The pattern of hybridization obtained with rat liver regucalcin cDNA is shown. The arrowhead indicates hybridizing bands 
corresponding to mRNA encoding the regucalcin. The figure shows one of four experiments with separate rats. 
mRNA levels in the liver of rats, while calcium admini- 
stration induced a remarkable increase in hepatic 
regucalcin mRNA levels. Thus, regucalcin mRNA ex- 
pression was uniquely stimulated by calcium out of the 
various metals used. Then, we further tested the ffect 
of TFP, an antagonist of calmodulin, on the expression 
of regucalcin mRNA in rat liver. It is known that TFP 
inhibits various enzymes and biological processes that 
are stimulated by calmodulin in the presence of Ca2+ 
]14]. Also, calmodulin is known to exist in rat liver 
nuclei [15]. Present data show that TFP completely 
blocked the expression of hepatic regucalcin mRNA as 
increased by the administration of calcium. This sug- 
gests that regucalcin mRNA expression is activated by 
Ca2’/calmodulin. Presumably, the expression of 
regucalcin mRNA in rat liver is mediated through a 
certain intermediate protein which is phosphorylated by 
Ca*‘/calmodulin-dependent protein kinase [16]. The 
mechanism related to phosphorylation of intermediate 
protein in liver nuclei remains to be elucidated. 
Phorbol myristate acetate (PMA) can activate a pro- 
tein kinase C (PKC) in the same way as diacylglycerol 
[ 171. PKC is located in rat liver nuclei [18]. PMA was 
intraperitoneally administered in rats to see whether 
PKC activation can regulate hepatic regucalcin mRNA 
levels. The administration of PMA (10~1,000 ~UgllOO g 
body weight) to rats did not cause an appreciable alter- 
ation of the regucalcin mRNA level in the liver. Presum- 
ably, the expression of hepatic regucalcin mRNA may 
not be mediated through protein kinase C. 
The palindromic consensus sequence (TGACGTCA), 
which functions as a CAMP-responsive element (CRE), 
was found in the S-flanking region in the human 
glycoprotein hormone a-subunit gene [ 191. CRE-bind- 
ing protein (CREB), which binds to a specific sequence 
(TGACGTCA), is phosphorylated by CAMP-depend- 
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ent protein kinase and the CRE-phosphorylated CREB 
complex stimulates transcription [20]. Then the effect of 
dibutyryl CAMP on the expression of regucalcin mRNA 
in rat liver was also examined. Dibutyryl CAMP was 
intraperitoneally administered to rats at a dose of lo- 
1,000 ,ug/lOO g body weight. The administration of di- 
butyryl CAMP did not result in alteration of the expres- 
sion level of mRNA encoding regucalcin in the liver, 
suggesting that the gene encoding regucalcin does not 
have CRE. 
In conclusion, the present study using Northern blot 
analyses demonstrates that the calcium administration- 
increased expression of hepatic regucalcin mRNA was 
clearly inhibited by the administration of an antagonist 
of calmodulin (TFP), suggesting that the gene expres- 
sion of regucalcin may be mediated through a Ca2’/ 
calmodulin-dependent protein kinase. Regucalcin 
mRNA expression may not be involved in other protein 
kinases such as protein kinase C and CAMP-dependent 
protein kinase. 
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